Evidence map›Paper›PMID 24831819›Full record

ArticleGenetics2014

Bypassing the requirement for an essential MYST acetyltransferase.

Ana Lilia Torres-Machorro, Lorraine Pillus

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ana Lilia Torres-MachorroSection of Molecular Biology, Division of Biological Sciences, University of California, San Diego, University of California at San Diego Moores Cancer Center, La Jolla, California 92093-0347.
Lorraine PillusSection of Molecular Biology, Division of Biological Sciences, University of California, San Diego, University of California at San Diego Moores Cancer Center, La Jolla, California 92093-0347 lpillus@ucsd.edu.
University of California, San Diego · US

Funding

NIGMS NIH HHS GM5649
6 · The paper itself

Abstract

Histone acetylation is a key regulatory feature for chromatin that is established by opposing enzymatic activities of lysine acetyltransferases (KATs/HATs) and deacetylases (KDACs/HDACs). Esa1, like its human homolog Tip60, is an essential MYST family enzyme that acetylates histones H4 and H2A and other nonhistone substrates. Here we report that the essential requirement for ESA1 in Saccharomyces cerevisiae can be bypassed upon loss of Sds3, a noncatalytic subunit of the Rpd3L deacetylase complex. By studying the esa1∆ sds3∆ strain, we conclude that the essential function of Esa1 is in promoting the cellular balance of acetylation. We demonstrate this by fine-tuning acetylation through modulation of HDACs and the histone tails themselves. Functional interactions between Esa1 and HDACs of class I, class II, and the Sirtuin family define specific roles of these opposing activities in cellular viability, fitness, and response to stress. The fact that both increased and decreased expression of the ESA1 homolog TIP60 has cancer associations in humans underscores just how important the balance of its activity is likely to be for human well-being.

Indexed as

Genes, EssentialAcetylationCell CycleDNA DamageDNA RepairGene DeletionGenetic FitnessHistone AcetyltransferasesHistone DeacetylasesHistonesModels, BiologicalMutationProtein BindingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTemperatureEsa1 protein, S cerevisiaeHistone AcetyltransferasesHistone DeacetylasesHistonesSaccharomyces cerevisiae ProteinsSDS3 protein, S cerevisiaeDNA damage repairESA1/KAT5HDACsRpd3LTip60

Identifiers

PMID24831819
PMCPMC4096366
OpenAlexW2170405043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.